Radim Sladkovsk - CEZ A Director Section
Insider
Radim Sladkovsk is Director Section of CEZ A S
| Age | 56 |
| Phone | 420 2 1104 1111 |
| Web | https://www.cez.cz |
CEZ A Management Efficiency
The company has return on total asset (ROA) of 0.0306 % which means that it generated a profit of $0.0306 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.4104 %, meaning that it generated $0.4104 on every $100 dollars invested by stockholders. CEZ A's management efficiency ratios could be used to measure how well CEZ A manages its routine affairs as well as how well it operates its assets and liabilities.CEZ A S has accumulated 95.92 B in total debt with debt to equity ratio (D/E) of 1.24, which is about average as compared to similar companies. CEZ A S has a current ratio of 0.93, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist CEZ A until it has trouble settling it off, either with new capital or with free cash flow. So, CEZ A's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CEZ A S sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CEZ to invest in growth at high rates of return. When we think about CEZ A's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Krista Fogarty | Lipocine | 57 | |
| Michael Ackermann | Tarsus Pharmaceuticals | 42 | |
| Quinn Deveraux | Inhibrx | N/A | |
| Logan Morse | Lipocine | 55 | |
| Michael Boehler | BioNTech SE | N/A | |
| David Nakasone | Tarsus Pharmaceuticals | N/A | |
| CPA CPA | Lipocine | 54 | |
| M MD | Lipocine | 66 | |
| BS CPA | Inhibrx | 42 | |
| Yuquan Wang | Futuretech II Acquisition | 52 | |
| Sierk Poetting | BioNTech SE | 52 | |
| Seshadri Neervannan | Tarsus Pharmaceuticals | 56 | |
| CFP CFP | Futuretech II Acquisition | 61 | |
| Mark Lappe | Inhibrx | 58 | |
| Ozlem MD | BioNTech SE | 58 | |
| Leonard JD | Tarsus Pharmaceuticals | 48 | |
| Dianne MSW | Tarsus Pharmaceuticals | 47 | |
| Jens Holstein | BioNTech SE | 62 | |
| Bobak MD | Tarsus Pharmaceuticals | N/A | |
| Ryan Richardson | BioNTech SE | 46 | |
| Elizabeth MD | Tarsus Pharmaceuticals | 47 | |
Management Performance
| Return On Equity | 0.41 | |||
| Return On Asset | 0.0306 |
CEZ A S Leadership Team
Elected by the shareholders, the CEZ A's board of directors comprises two types of representatives: CEZ A inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CEZ. The board's role is to monitor CEZ A's management team and ensure that shareholders' interests are well served. CEZ A's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CEZ A's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ju MBA, Chief Director | ||
| Barbara Seidlova, Head of Investor Relations | ||
| Engineer MBA, Chairman CEO | ||
| Engineer Cyrani, Deputy Chairman | ||
| Bohdana Horackova, New Director | ||
| Radim Sladkovsk, Director Section | ||
| Libuse Latalova, Head Admin | ||
| Tomas MBA, Chief Energy | ||
| Juraj Szab, Director Section |
CEZ Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is CEZ A a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.41 | |||
| Return On Asset | 0.0306 | |||
| Profit Margin | 0.20 % | |||
| Current Valuation | 23.51 B | |||
| Shares Outstanding | 536.79 M | |||
| Shares Owned By Insiders | 69.70 % | |||
| Shares Owned By Institutions | 4.20 % | |||
| Price To Earning | 13.58 X | |||
| Price To Book | 4.57 X | |||
| Price To Sales | 1.15 X |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Consideration for investing in CEZ Pink Sheet
If you are still planning to invest in CEZ A S check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CEZ A's history and understand the potential risks before investing.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |